Skip to content

Noncardiac Surgery Timing & Cardiovascular Risk Database ​

Clinical search topic · Checked 2026-11-19

Use the site-wide Search control for: PCI, balloon, BMS, DES, ACS, DAPT, CABG, 100 days, myocardial infarction, NSTEMI, STEMI, stroke, and TIA.

Interactive clinical database ​

Showing 11 / 11 records

PCIGuideline

Balloon angioplasty without stent

Delay elective noncardiac surgery for at least 14 days

2026 AHA/ACC guideline: COR I, LOE C-LD

PCIGuideline

Bare-metal stent (BMS)

Elective surgery requiring antiplatelet interruption within 30 days may be harmful

2026 AHA/ACC guideline: COR III (Harm), LOE B-NR

PCIGuideline

Drug-eluting stent (DES) for ACS

Ideally delay elective surgery ≥12 months; time-sensitive surgery may be considered ≥3 months after PCI in selected cases

2026 AHA/ACC guideline: elective COR I / LOE B-NR; time-sensitive COR IIb / LOE B-NR

PCIGuideline

Drug-eluting stent (DES) for chronic coronary disease (CCD)

If antiplatelet interruption is required, delay elective surgery ≥6 months; selected time-sensitive surgery may be considered ≥3 months after PCI

2026 AHA/ACC guideline: elective COR IIa / LOE B-NR; time-sensitive COR IIb / LOE B-NR

CABGGuideline

After coronary artery bypass grafting (CABG)

An observational study found a risk-curve inflection around 100 days; this is not a guideline-defined minimum interval

2025 JACC: Advances retrospective national database study; not a COR/LOE guideline recommendation

MIGuideline

After non-ST-elevation myocardial infarction (NSTEMI)

In older revascularized patients, 90–180 days may be a reasonable elective-surgery optimization window; do not generalize to all MI

2025 JAMA Surgery Medicare observational study; not a universal guideline interval

Stroke/TIAGuideline

After ischemic stroke or transient ischemic attack (TIA)

Elective noncardiac surgery: delay at least 3 months after the most recent event

2026 AHA/ACC guideline: COR IIa, LOE B-NR

CEAObservational

Carotid endarterectomy (CEA) and subsequent noncardiac surgery

Symptomatic carotid stenosis: perform revascularization as soon as appropriate, preferably within 14 days; after CEA, no universally validated fixed delay exists for unrelated elective surgery

ESVS 2023: revascularization within 14 days, Class I / Level A; interval to unrelated NCS after CEA: insufficient evidence

Open guideline / source ↗

CASObservational

Carotid artery stenting (CAS) and subsequent noncardiac surgery

For symptomatic stenosis requiring revascularization within 14 days, CEA is preferred over CAS; after CAS, no universal fixed interval for unrelated NCS is established, and premature DAPT interruption should be avoided

ESVS 2023: CEA preferred when revascularization is required in first 14 days, Class I / Level A; direct evidence for NCS timing after CAS is lacking

Open guideline / source ↗

ICHGuideline

Elective noncardiac surgery after spontaneous intracerebral hemorrhage (ICH)

No universally applicable fixed waiting interval is established by high-quality guidelines; assess elective surgery individually after hematoma stability, cause/BP control, correction of coagulopathy, and neurologic stabilization

2022 AHA/ASA spontaneous ICH guideline: no universal interval for elective non-neurosurgical procedures; this remains an evidence gap

Open guideline / source ↗

TAVR/TAVIGuideline

After transcatheter aortic valve replacement (TAVR/TAVI)

After successful TAVI, NCS may be performed early when clinically indicated; evidence supports surgery within 30 days (no routine mandatory 30-day delay)

2026 AHA/ACC perioperative guideline (reaffirming 2024): COR IIa, LOE B-NR

Open guideline / source ↗

For professional education and decision support. Verify each case against the current full guideline and multidisciplinary assessment.

Quick index ​

ScenarioKey timingEvidence type
PCI: balloon / BMS / DES14 days / 30 days / 3, 6, 12 monthsAHA/ACC guideline
After CABGApprox. 100-day risk inflection2025 observational study; not a guideline minimum
After NSTEMI30 days, 90 days, 90–180-day research signal2025 JAMA Surgery observational study
After ischemic stroke / TIA≥3 monthsAHA/ACC guideline COR 2a / LOE B-NR

Noncardiac surgery after PCI ​

Guideline recommendation 2026 AHA/ACC multisociety perioperative guideline (reaffirmed in 2026; recommendations unchanged from 2024). These intervals address NCS requiring interruption of at least one antiplatelet agent; they are not automatic clearance dates.
PCI type / indicationElective surgery delayTime-sensitive surgeryCOR / LOE
Balloon angioplasty without stentAt least 14 daysNo generally applicable shorter safe interval; individualizeI / C-LD
Bare-metal stent (BMS)At least 30 daysElective surgery requiring antiplatelet interruption within 30 days may be harmfulIII (Harm) / B-NR
Drug-eluting stent (DES) for ACSIdeally at least 12 monthsMay be considered ≥3 months after PCI if delay risk outweighs cardiac riskElective I / B-NR; time-sensitive IIb / B-NR
DES for chronic coronary disease (CCD)At least 6 monthsMay be considered ≥3 months if delay risk outweighs cardiac riskElective IIa / B-NR; time-sensitive IIb / B-NR
BMS or DES implanted ≤30 daysDo not perform elective NCS requiring interruption of ≥1 antiplatelet agentIf surgery cannot be deferred, multidisciplinary decision-making is requiredIII (Harm) / B-NR

Clinical notes:

  • If no contraindication, continue aspirin 75–100 mg/day perioperatively in patients with prior PCI (I / B-R).
  • For time-sensitive NCS within 30 days after BMS-PCI or within 3 months after DES-PCI, continue DAPT unless bleeding risk outweighs benefit (I / B-NR).
  • After DES-PCI for ACS, elective surgery should ideally be delayed ≥12 months; complex PCI may warrant longer.
  • Record PCI date, indication, balloon/BMS/DES, stent number and complexity, proposed antiplatelet interruption, bleeding consequences, and harm from delaying surgery.
  • Reaching a time threshold does not mean stent-thrombosis risk is zero.

Noncardiac surgery after CABG ​

Observational evidence · Not a mandatory guideline waiting period

A 2025 national database study, Evaluation of the Timing to Noncardiac Surgery following Cardiac Operations: A National Analysis (JACC: Advances, 2025), included US adults undergoing CABG, valve, or combined cardiac surgery followed by NCS during 2016–2020.

  • The risk curve showed an inflection point at approximately 100 days after cardiac surgery.
  • Compared with NCS within 100 days, NCS at ≥100 days was associated with lower adjusted odds of major adverse events (aOR 0.69, 95% CI 0.62–0.76) and in-hospital mortality (aOR 0.66, 95% CI 0.46–0.96).
  • This retrospective cohort included CABG and other cardiac-surgery subgroups. It cannot establish 100 days as a causal safety boundary or a mandatory waiting period for every CABG patient.

Record CABG date and concomitant valve surgery; wound/sternal healing; residual ischemia, heart failure, arrhythmia, anemia, renal dysfunction or infection; LV function and functional capacity; NCS urgency and bleeding risk; and ongoing DAPT. If feasible, approximately 100 days may be discussed as an observational risk-optimization signal. Urgent surgery should not be automatically cancelled solely because 100 days have not elapsed.

Noncardiac surgery after myocardial infarction ​

Observational NSTEMI evidence; do not generalize to all MI

Guideline status: the reaffirmed 2026 AHA/ACC perioperative guideline emphasizes appropriate evaluation/treatment of ACS and deferral of elective surgery when ACS is present. It does not provide one universal waiting interval after any MI independent of PCI status, LV function, and clinical stability.

Key study: Glance et al. Time Since Prior NSTEMI and Major Adverse Cardiovascular and Cerebrovascular Events After Noncardiac Surgery. JAMA Surgery. 2025;160(1):45–54. DOI: 10.1001/jamasurg.2024.4683.

  • US Medicare data from 2015–2020; patients aged ≥67 years undergoing major NCS; 42,278 had prior NSTEMI.
  • Surgery within 30 days after NSTEMI was associated with approximately twice the MACCE odds, whether or not revascularization had been performed (aOR 2.15 and 2.04).
  • In revascularized patients, MACCE odds leveled off after 30 days; in the DES subgroup, after approximately 90 days.
  • In patients without revascularization, the study did not show a clear plateau in MACCE odds.
  • The authors concluded that delaying elective surgery to 90–180 days may be reasonable for older NSTEMI patients who underwent revascularization.

Interpretation:

  • 90–180 days is an observational risk-optimization window, not a universal mandatory interval in the 2026 AHA/ACC guideline.
  • The study involved older Medicare patients with NSTEMI; do not automatically extrapolate to younger patients, STEMI, all MI phenotypes, or every surgical-risk category.
  • If PCI was performed after MI, also apply stent-specific, ACS/CCD, DAPT, and bleeding-risk recommendations. Do not calculate timing from the MI date alone.
  • Do not assume a stable risk plateau after 90 days in patients without revascularization.
  • Assess ongoing ischemia, heart failure, arrhythmia, hemodynamic instability, and incomplete ACS treatment before surgery. Active acute cardiac conditions warrant deferral of elective surgery and treatment first.

Noncardiac surgery after ischemic stroke or TIA ​

Guideline recommendation 2026 AHA/ACC multisociety perioperative guideline (recommendation unchanged from 2024).

In patients with prior stroke or transient ischemic attack (TIA), it is reasonable to delay elective NCS for ≥3 months after the most recent cerebrovascular event to reduce recurrent stroke, MACE, or both. COR 2a; LOE B-NR.

  • Perioperative risk decreases over time after stroke, but evidence defining the optimal delay is limited.
  • This recommendation concerns elective NCS; it does not mean all urgent operations must wait 3 months.
  • Record event date and type, etiology, neurologic deficits, swallowing/airway protection, cognition, thrombolysis/thrombectomy/CEA/CAS, antithrombotic regimen, AF/carotid stenosis, blood pressure, and cerebral perfusion concerns.
  • Intracerebral hemorrhage (ICH) is not directly covered by this ≥3-month recommendation. Timing after ICH requires separate assessment of cause, hematoma stability, imaging, neurologic status, and antithrombotic therapy.

Search terms ​

  • PCI: balloon, BMS, DES, ACS, CCD, DAPT
  • CABG: coronary bypass, 100 days, graft
  • MI: myocardial infarction, NSTEMI, STEMI, revascularization
  • Cerebrovascular: stroke, TIA, 3 months, cerebral perfusion

Guideline recommendations and observational evidence are distinguished. COR/LOE are shown only when specified in the source; grades are not invented for observational studies.

For professional education and decision support. This database does not replace full guidelines, specialty consultation, institutional policy, or individualized clinical judgment. Emergency surgery should not be delayed solely because of one time threshold.

Primary sources ​

  1. 2026 AHA/ACC multisociety perioperative guideline (JACC)
  2. AHA official 2026 guideline page and reaffirmation statement
  3. 2026 AHA/ACC guideline (Circulation)
  4. 2025 national database study after CABG/cardiac surgery (open full text)
  5. 2025 NSTEMI timing study (JAMA Surgery)
  6. 2024 AHA/ACC original guideline text (reaffirmed in 2026; unchanged)

Version record: Checked 2026-11-19. The 2026 AHA/ACC guideline has been reaffirmed. CABG and NSTEMI timing signals are observational evidence and require ongoing review and local clinical validation.

For professional education and decision support. Verify recommendations against current guidelines and patient-specific factors.